Navigation Links
Researchers identify cancer preventive properties in common vitamin supplement
Date:7/6/2008

PHILADELPHIA Early laboratory research has shown that resveratrol, a common dietary supplement, suppresses the abnormal cell formation that leads to most types of breast cancer, suggesting a potential role for the agent in breast cancer prevention. Resveratrol is a natural substance found in red wine and red grapes. It is sold in extract form as a dietary supplement at most major drug stores.

"Resveratrol has the ability to prevent the first step that occurs when estrogen starts the process that leads to cancer by blocking the formation of the estrogen DNA adducts. We believe that this could stop the whole progression that leads to breast cancer down the road," said Eleanor G. Rogan, Ph.D., a professor in the Eppley Institute for Research in Cancer and Allied Diseases at the University of Nebraska Medical Center.

Rogan was the lead author of the report that was published in the July 2008 issue of Cancer Prevention Research, a journal of the American Association for Cancer Research.

For the current study, Rogan and colleagues measured the effect of resveratrol on cellular functions known to contribute to breast cancer.

The formation of breast cancer is a multi-step process which differs depending on type of disease, a patient's genetic makeup and other factors. However, scientists know that many breast cancers are fueled by increased estrogen, which collects and reacts with DNA molecules to form adducts. Rogan and colleagues found that resveratrol was able to suppress the formation of these DNA adducts.

"This is dramatic because it was able to be done with fairly low concentrations of resveratrol to stop the formation of these DNA adducts in the cells we studied," said Rogan. Although researchers experimented with up to 100 mol/L of resveratrol, the suppression of DNA adducts was seen with 10 mol/L. A glass of red wine contains between 9 and 28 mol/L of resveratrol.

The researchers also found that resveratrol suppressed the expression of CYP1B1 and the formation of 2,3,7,8-Tetrachlorodibenzo-p-dioxin, two known risk factors for breast cancer.

Rogan said resveratrol works by inducing an enzyme called quinone reductase, which reduces the estrogen metabolite back to inactive form. By making estrogen inactive, resveratrol decreases the associated risk.

The current study was conducted in laboratory cultures, and will need to be confirmed in larger human trials, Rogan said.


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. UT Southwestern researchers identify new targets for RNAs that regulate genes
2. UCLA researchers clarify function of glucose transport molecule
3. UC San Diego researchers identify potential new drug candidates to combat bird flu
4. Texas A&M researchers develop tool to study complex clusters of genes
5. Weekends slow weight loss, researchers find
6. Researchers coat titanium with polymer to improve integration of joint replacements
7. Researchers link early stem cell mutation to autism
8. Montreal Heart Institute and Mount Sinai Hospital researchers contribute to Crohns disease study
9. Salk researchers reprogram adult stem cells in their natural environment
10. UIC researchers make promising finding in severe lung disease
11. Montana State researchers release guide to noninvasive carnivore research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... The report "Biometric Vehicle Access ... (Iris Recognition System), Vehicle Type (Passenger Car, Battery ... 2021", published by MarketsandMarkets, the market is estimated ... is projected to grow to USD 854.8 Million ...      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... Poland , Nov. 30, 2016 Not many of us realize that ... aspects of recovery so we need to do it well. Inadequate sleep levels have ... high blood pressure, stroke, diabetes, and even cancer. Maybe now is the ... present that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016  Muse bio, a privately-held ... today announced that Dr. Kevin Ness has ... Board of Directors. Kevin succeeds Muse ... the company,s Chief Science Officer as well as remains ... of the BioDesign Center at the RAS Energy Institute ...
(Date:12/7/2016)... Maryland (PRWEB) , ... December 07, 2016 , ... ... for digital pathology, announced today a new service to enable rapid migration of ... data upload has remained one of the factors limiting adoption of digital pathology. ...
(Date:12/6/2016)... Texas , Dec. 6, 2016 The ... for its adoption of arnica ( Arnica montana ... support to ABC,s HerbMedPro database, a ... important scientific and clinical research data on the ... popular herbs. Naturopathica, a wellness company ...
(Date:12/6/2016)... ... December 06, 2016 , ... Discovering new clues to ... see with lasers what’s happening in our brains. And searching for keys to our ... in research being honored with the 2017 Edith and Peter O’Donnell Awards ...
Breaking Biology Technology: